Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine as anaesthetic during ECT for depression
2011-000396-14Phase 4Completed
- Sponsor
- University of Aberdeen
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ketamine in major depressive disorder (MDD) (2 arms), sponsored by University of Aberdeen. Primary endpoint: Change in depressive symptoms after the fourth ECT treatment. Started Apr 2011; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2011-000396-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000396-14.